Skip to content
About CombiGene
Projects
The pain program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association
Company description
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
About CombiGene
Projects
The pain program COZY
The epilepsy project CG01
The lipodystrophy project CGT2
Patent
The Market
Organization
Investors
Financial reports
Prospectus/IM
Financial calendar
Company and share information
Nasdaq First North Growth Market
Corporate governance
Organization
Articles of association
Company description
IR-contact
Certified Adviser
Media
Press releases
Presentations
Ingeneious
Calendar
Contact
Contact us
Downloads
SV
Contact
Peter Ekolind
CEO
Envelope
Karin Agerman
Chief Scientific Officer
Envelope
Louise Aspenberg
Chief Financial Officer
Envelope
Jan Nilsson
Senior Executive Advisor
Envelope
Sebastian Bauer
Director CMC
Envelope
Annika Ericsson
Director Preclinical Development
Envelope
Pernilla Fagergren
Director Clinical Development
Envelope
Alvar Grönberg
Senior Program Director
Envelope
Birgitta Ståhl
Senior Director In-licensing
Envelope
Esbjörn Melin
Scientist
Envelope
Daniela Morath
Corporate Administration
Envelope
